The baseline frequency of CD69+CD4+ T cells was higher in subjects who presented with skin reactions during benznidazole therapy than that of the uninfected group (Fig. 4A to C), whereas the frequency of CD69+CD8+ T cells was not different among groups (Fig. 4D). This evidence concerns the gene CD4 and skin reaction.